{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:32:42Z","timestamp":1769826762633,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ae0101016s0904"],"award-info":[{"award-number":["17ae0101016s0904"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K11330"],"award-info":[{"award-number":["16K11330"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09981"],"award-info":[{"award-number":["19K09981"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09959"],"award-info":[{"award-number":["19K09959"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n              <jats:title>Purpose<\/jats:title>\n              <jats:p>MicroRNAs (miRNAs) are non-coding RNAs which have attracted attention as biomarkers in a variety of diseases. However, extensive unbiased analysis of miRNA in vitreous humor of sarcoidosis patients has not been reported. In the present study, we comprehensively analyzed the dysregulated miRNAs in ocular sarcoidosis to search for potential biomarkers.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Materials and Methods<\/jats:title>\n              <jats:p>This study included seven patients diagnosed with ocular sarcoidosis (five definite and two presumed). Five patients with unclassified uveitis and 24 with non-inflammatory diseases served as controls. MicroRNA expression levels in vitreous humor samples were measured by microarray, and differentially expressed miRNAs between sarcoidosis and other diseases were explored. Next, pathway enrichment analysis was performed to evaluate the functions of the dysregulated miRNAs, and machine learning was used to search for candidate biomarkers.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Results<\/jats:title>\n              <jats:p>A total of 614 upregulated miRNAs and 8 downregulated miRNAs were detected in vitreous humor of patients with ocular sarcoidosis compared with patients with unclassified uveitis and non-inflammatory diseases. Some dysregulated miRNAs were involved in the TGF-\u03b2 signaling pathway. Furthermore, we identified miR-764 as the best predictor for ocular sarcoidosis using Boruta selection.<\/jats:p>\n            <\/jats:sec><jats:sec>\n              <jats:title>Conclusions<\/jats:title>\n              <jats:p>In this study, comprehensive miRNA analysis of vitreous humor samples identified dysregulated miRNAs in ocular sarcoidosis. This study suggests new insights into molecular pathogenetic mechanisms of sarcoidosis and may provide useful information toward developing novel diagnostic biomarkers and therapeutic targets for sarcoidosis.<\/jats:p>\n            <\/jats:sec>","DOI":"10.1007\/s00417-024-06619-2","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:03:00Z","timestamp":1725872580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive microRNA analyses using vitreous humor of ocular sarcoidosis"],"prefix":"10.1007","author":[{"given":"Masaki","family":"Asakage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-3587","authenticated-orcid":false,"given":"Yoshihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinya","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"6619_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10384-006-0383-4","volume":"51","author":"H Goto","year":"2007","unstructured":"Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S (2007) Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 51:41\u201344. https:\/\/doi.org\/10.1007\/s10384-006-0383-4","journal-title":"Jpn J Ophthalmol"},{"key":"6619_CR2","doi-asserted-by":"publisher","unstructured":"Kunimi K, Usui Y, Tsubota K et al (2020) Changes in Etiology of Uveitis in a Single Center in Japan. Ocul Immunol Inflamm 1\u20136. https:\/\/doi.org\/10.1080\/09273948.2019.1709649","DOI":"10.1080\/09273948.2019.1709649"},{"key":"6619_CR3","doi-asserted-by":"publisher","first-page":"e0147258","DOI":"10.1371\/journal.pone.0147258","volume":"11","author":"E Gundlach","year":"2016","unstructured":"Gundlach E, Hoffmann MM, Prasse A, Heinzelmann S, Ness T (2016) Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis. PLoS ONE 11:e0147258. https:\/\/doi.org\/10.1371\/journal.pone.0147258","journal-title":"PLoS ONE"},{"key":"6619_CR4","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/s0161-6420(95)30763-4","volume":"102","author":"WJ Power","year":"1995","unstructured":"Power WJ, Neves RA, Rodriguez A, Pedroza-Seres M, Foster CS (1995) The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology 102:2007\u20132011. https:\/\/doi.org\/10.1016\/s0161-6420(95)30763-4","journal-title":"Ophthalmology"},{"key":"6619_CR5","doi-asserted-by":"publisher","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","volume":"3","author":"S Gilad","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y et al (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3:e3148. https:\/\/doi.org\/10.1371\/journal.pone.0003148","journal-title":"PLoS ONE"},{"key":"6619_CR6","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6619_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jmoldx.2013.07.005","volume":"15","author":"IS Sourvinou","year":"2013","unstructured":"Sourvinou IS, Markou A, Lianidou ES (2013) Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn 15:827\u2013834. https:\/\/doi.org\/10.1016\/j.jmoldx.2013.07.005","journal-title":"J Mol Diagn"},{"key":"6619_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997\u20131006. https:\/\/doi.org\/10.1038\/cr.2008.282","journal-title":"Cell Res"},{"key":"6619_CR9","doi-asserted-by":"publisher","unstructured":"Lin JB, Moolani HV, Sene A et al (2018) Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration. JCI Insight 3. https:\/\/doi.org\/10.1172\/jci.insight.120157","DOI":"10.1172\/jci.insight.120157"},{"key":"6619_CR10","doi-asserted-by":"publisher","unstructured":"Minezaki T, Usui Y, Asakage M et al (2020) High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis. J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9061844","DOI":"10.3390\/jcm9061844"},{"key":"6619_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.61.11.4","volume":"61","author":"M Asakage","year":"2020","unstructured":"Asakage M, Usui Y, Nezu N et al (2020) Comprehensive miRNA Analysis Using Serum From Patients With Noninfectious Uveitis. Invest Ophthalmol Vis Sci 61:4. https:\/\/doi.org\/10.1167\/iovs.61.11.4","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6619_CR12","doi-asserted-by":"publisher","first-page":"1246129","DOI":"10.1155\/2016\/1246129","volume":"2016","author":"E Novosadova","year":"2016","unstructured":"Novosadova E, Chabronova A, Kolek V, Petrek M, Navratilova Z (2016) The Serum Expression of Selected miRNAs in Pulmonary Sarcoidosis with\/without L\u00f6fgren\u2019s Syndrome. Mediators Inflamm 2016:1246129. https:\/\/doi.org\/10.1155\/2016\/1246129","journal-title":"Mediators Inflamm"},{"key":"6619_CR13","doi-asserted-by":"publisher","first-page":"121378","DOI":"10.1155\/2015\/121378","volume":"2015","author":"T Dyskova","year":"2015","unstructured":"Dyskova T, Fillerova R, Novosad T et al (2015) Correlation Network Analysis Reveals Relationships between MicroRNAs, Transcription Factor T-bet, and Deregulated Cytokine\/Chemokine-Receptor Network in Pulmonary Sarcoidosis. Mediators Inflamm 2015:121378. https:\/\/doi.org\/10.1155\/2015\/121378","journal-title":"Mediators Inflamm"},{"key":"6619_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/resp.13364","volume":"23","author":"A Kishore","year":"2018","unstructured":"Kishore A, Navratilova Z, Kolek V, Novosadova E, Cepe K, du Bois RM, Petrek M (2018) Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respirology 23:1166\u20131172. https:\/\/doi.org\/10.1111\/resp.13364","journal-title":"Respirology"},{"key":"6619_CR15","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418\u20131422. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313356","journal-title":"Br J Ophthalmol"},{"key":"6619_CR16","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.ophtha.2012.05.033","volume":"119","author":"K Kojima","year":"2012","unstructured":"Kojima K, Maruyama K, Inaba T et al (2012) The CD4\/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology 119:2386\u20132392. https:\/\/doi.org\/10.1016\/j.ophtha.2012.05.033","journal-title":"Ophthalmology"},{"key":"6619_CR17","doi-asserted-by":"publisher","first-page":"e014549","DOI":"10.1136\/bmjopen-2016-014549","volume":"7","author":"K Maruyama","year":"2017","unstructured":"Maruyama K, Inaba T, Sugita S et al (2017) Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study. BMJ Open 7:e014549. https:\/\/doi.org\/10.1136\/bmjopen-2016-014549","journal-title":"BMJ Open"},{"key":"6619_CR18","doi-asserted-by":"publisher","first-page":"e5531","DOI":"10.1097\/MD.0000000000005531","volume":"95","author":"K Maruyama","year":"2016","unstructured":"Maruyama K, Inaba T, Tamada T, Nakazawa T (2016) Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis. Medicine (Baltimore) 95:e5531. https:\/\/doi.org\/10.1097\/MD.0000000000005531","journal-title":"Medicine (Baltimore)"},{"key":"6619_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00005-014-0315-9","volume":"63","author":"A Jazwa","year":"2015","unstructured":"Jazwa A, Kasper L, Bak M et al (2015) Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis. Arch Immunol Ther Exp (Warsz) 63:139\u2013146. https:\/\/doi.org\/10.1007\/s00005-014-0315-9","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"6619_CR20","doi-asserted-by":"publisher","first-page":"527433","DOI":"10.3389\/fmed.2020.527433","volume":"7","author":"YB Zhao","year":"2020","unstructured":"Zhao YB, Li W, Zhang Q et al (2020) Distinct miRNA gene expression profiles among the nodule tissues of lung sarcoidosis, tuberculous lymphadenitis and normal healthy control individuals. Front Med (Lausanne) 7:527433. https:\/\/doi.org\/10.3389\/fmed.2020.527433","journal-title":"Front Med (Lausanne)"},{"key":"6619_CR21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41598-020-57588-5","volume":"10","author":"MR Kalhori","year":"2020","unstructured":"Kalhori MR, Arefian E, Fallah Atanaki F, Kavousi K, Soleimani M (2020) miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K\/AKT signaling pathway in Glioblastoma cell lines. Sci Rep 10:1558. https:\/\/doi.org\/10.1038\/s41598-020-57588-5","journal-title":"Sci Rep"},{"key":"6619_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bulcan.2021.11.017","volume":"109","author":"F Lin","year":"2022","unstructured":"Lin F, Li R (2022) MiR-1226, mediated by ASCL1, suppresses the progression of non-small cell lung cancer by targeting FGF2. Bull Cancer 109:424\u2013435. https:\/\/doi.org\/10.1016\/j.bulcan.2021.11.017","journal-title":"Bull Cancer"},{"key":"6619_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.kjms.2018.04.005","volume":"34","author":"ZY Niu","year":"2018","unstructured":"Niu ZY, Li WL, Jiang DL, Li YS, Xie XJ (2018) Mir-483 inhibits colon cancer cell proliferation and migration by targeting TRAF1. Kaohsiung J Med Sci 34:479\u2013486. https:\/\/doi.org\/10.1016\/j.kjms.2018.04.005","journal-title":"Kaohsiung J Med Sci"},{"key":"6619_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2337\/db18-0084","volume":"68","author":"K Kuschnerus","year":"2019","unstructured":"Kuschnerus K, Straessler ET, Muller MF, Luscher TF, Landmesser U, Krankel N (2019) Increased expression of miR-483-3p Impairs the vascular response to injury in type 2 diabetes. Diabetes 68:349\u2013360. https:\/\/doi.org\/10.2337\/db18-0084","journal-title":"Diabetes"},{"issue":"2488\u20132496","key":"6619_CR25","doi-asserted-by":"publisher","first-page":"e2484","DOI":"10.1016\/j.jid.2019.03.1161","volume":"139","author":"R Zeng","year":"2019","unstructured":"Zeng R, Xu H, Liu Y et al (2019) miR-146a inhibits biofilm-derived cutibacterium acnes-induced inflammatory reactions in human keratinocytes. J Invest Dermatol 139(2488\u20132496):e2484. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1161","journal-title":"J Invest Dermatol"},{"key":"6619_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.reumae.2020.08.005","volume":"17","author":"S Kobak","year":"2021","unstructured":"Kobak S, Akyildiz M, Gokduman A, Atabay T, Vural H (2021) Serum galectin-3 and TGF-beta levels in patients with sarcoidosis. Reumatol Clin (Engl Ed) 17:562\u2013565. https:\/\/doi.org\/10.1016\/j.reumae.2020.08.005","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"6619_CR27","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/jbmr.1597","volume":"27","author":"J Guo","year":"2012","unstructured":"Guo J, Ren F, Wang Y et al (2012) miR-764-5p promotes osteoblast differentiation through inhibition of CHIP\/STUB1 expression. J Bone Miner Res 27:1607\u20131618. https:\/\/doi.org\/10.1002\/jbmr.1597","journal-title":"J Bone Miner Res"},{"key":"6619_CR28","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.12659\/MSM.893082","volume":"21","author":"Y Chen","year":"2015","unstructured":"Chen Y, Chen J, Liu Y, Li S, Huang P (2015) Plasma miR-15b-5p, miR-338\u20135p, and miR-764 as biomarkers for hepatocellular carcinoma. Med Sci Monit 21:1864\u20131871. https:\/\/doi.org\/10.12659\/MSM.893082","journal-title":"Med Sci Monit"},{"key":"6619_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342. https:\/\/doi.org\/10.1038\/nature01658","journal-title":"Nature"},{"key":"6619_CR30","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.4049\/jimmunol.0711823","volume":"182","author":"T Totsuka","year":"2009","unstructured":"Totsuka T, Kanai T, Nemoto Y et al (2009) RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis. J Immunol 182:6079\u20136087. https:\/\/doi.org\/10.4049\/jimmunol.0711823","journal-title":"J Immunol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06619-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:09:11Z","timestamp":1725916151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06619-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":30,"alternative-id":["6619"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06619-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tokyo Medical University Hospital (No. 2016\u2013162). The study was performed in accordance with the ethical standards as laid down in the\u00a01964 Declaration of Helsinki\u00a0and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no financial or proprietary interests in any material discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}